4 insiders bought €5.5M of shares over the last 90 days, the latest filed 29 Sept 2026.
Cluster: 4 buyers in 30 daysEvery trade that managers of Futura Medical plc disclose to RNS (LSE) is tracked on this page. In the past year (18 October 2025 to 18 October 2026), 4 filings came from 4 insiders.
The flow runs one way only: 4 insiders bought (4 purchases totalling €55k) and nobody sold on the market. Unlike grants, an open-market purchase is paid for by the insider, at the market price. On the buying side, the filings list 2 board members, 1 senior executive and 1 chief executive among the declarants. The largest single trade was a purchase of €29k by Alexander Duggan, published on 29 September 2026, equal to 0.72% of the market capitalisation.
For context, the typical company on the same exchange (median of 833 companies) published 6 filings over the same period, against 4 filings here. The full history, which starts in 2026, counts 4 purchases against no sales.
In all, 4 purchases were made within 30 days of a purchase by another insider of the company. When several insiders buy within a few weeks of each other, analysts speak of a cluster purchase. The last purchase on record was published on 29 September 2026, which is 18 days ago. Filings reach the RNS (LSE) feed a median of 4 days after the trade. Under the UK Market Abuse Regulation, managers have three business days to notify their trades.
This summary is built from RNS (LSE) disclosures alone and does not predict where the share price will go.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
FY ended December 2025 · cache
4 of 4 declarations
Futura Medical plc is a UK-based company focused on the development of pharmaceutical and medical products. It primarily concentrates on treatments for men's health and healthcare products.